Top Markets
Coin of the day
Fresenius SE & Co. KGaA Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA

FSNUY
Classifica tra le azioni #183
Fresenius SE & Co. KGaA, a health care company, provides products and services... Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune and oncology diseases; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operates 90 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 49 hospitals, 88 outpatient clinics, and approximately 300 risk prevention centers in Spain. This segment also provides services in the field of fertility treatments through 33 clinics and additional 39 sites across 10 countries on 3 continents. The Fresenius Vamed segment manages projects and offers services for hospitals and other health care facilities. This segment provides project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
Prezzo delle azioni
$12.65
Capitalizzazione di mercato
$114.00B
Variazione (1 giorno)
1.36%
Variazione (1 anno)
3.52%
Paese
DE
Scambia Fresenius SE & Co. KGaA (FSNUY)

Categoria

Margine operativo per Fresenius SE & Co. KGaA (FSNUY)
Margine operativo al July 2026 TTM: 9.45%
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Fresenius SE & Co. KGaA, il margine operativo attuale (TTM) è 9.45%. Alla fine del 2023, il margine operativo era 5.13%.
Storico del margine operativo per Fresenius SE & Co. KGaA da 2002 a 2026
Margine operativo alla fine di ogni anno
Anno Margine Operativo Cambia
2026 (TTM) 9.45% 15.81%
2024 8.16% 59.06%
2023 5.13% -40.28%
2022 8.59% -22.47%
2021 11.08% -8.35%
2020 12.09% -7.57%
2019 13.08% -1.28%
2018 13.25% -2.14%
2017 13.54% -9.01%
2016 14.88% 6.06%
2015 14.03% 4.70%
2014 13.40% -8.91%
2013 14.71% -4.85%
2012 15.46% -0.32%
2011 15.51% 2.44%
2010 15.14% 4.27%
2009 14.52% 21.30%
2008 11.97% -68.59%
2007 38.11% 2.01%
2006 37.36% -6.13%
2005 39.80% 6.05%
2004 37.53% 250.09%
2003 10.72% -0.65%
2002 10.79% 0.00%
Margine operativo per aziende simili o concorrenti
Azienda Margine Operativo Differenza del margine operativo Il paese
15.67% -98.34%
US
18.60% -98.03%
SA
16.14% -98.29%
US
5.17% -99.45%
CN
15.01% -98.41%
US
Cos'è l'Margine operativo di un'azienda?
L'Margine operativo è un indicatore chiave per valutare la redditività di un'azienda. Margini operativi più elevati sono generalmente preferibili poiché indicano che l'azienda riesce a vendere i propri prodotti o servizi a un prezzo significativamente superiore rispetto ai costi di produzione. Si calcola dividendo gli utili per i ricavi.